文献速递神经肿瘤

CD97/ADGRE5 基因操作调控患者来源胶质瘤干细胞侵袭

Genetic manipulation of adhesion GPCR CD97/ADGRE5 modulates invasion in patient-derived glioma stem cells.
PubMed 文献 · J Neurooncol · 2021-05-24

本研究在来自5例GBM患者的原代胶质瘤干细胞(pdGSC)中考察CD97功能,比较其内源水平与患者MRI侵袭模式及体外侵袭率,并通过敲低和过表达分析干细胞标志、侵袭和增殖。结果显示CD97水平与影像侵袭性和体外侵袭率正相关,敲低降低侵袭、过表达增加侵袭,效应呈亚型依赖;在最低内源CD97细胞系中过表达使增殖率增加近三倍。

要点

  • CD97内源水平与患者MRI侵袭模式及体外侵袭率正相关
  • CD97敲低降低pdGSC体外侵袭,间质型和经典型更明显
  • CD97过表达增加前神经型pdGSC侵袭,最低表达系增殖近三倍

核心结论

  • 首次在pdGSC中证明CD97敲低降低、过表达增加体外侵袭率。
  • CD97对侵袭的效应呈pdGSC亚型依赖。
  • 需未来体内和机制研究验证,并应寻找CD97药理抑制剂以潜在削弱GBM侵袭。

研究设计与样本

  • 研究使用来自5例GBM肿瘤的原代患者来源胶质瘤干细胞(pdGSC),涵盖三个主要遗传亚型。
  • 比较pdGSC内源CD97水平与对应患者MRI影像侵袭模式侵袭性。
  • 通过敲低和过表达操作CD97,分析干细胞与亚型标志表达、体外侵袭特性和细胞增殖。

主要发现

  • pdGSC内源CD97水平与患者MRI影像侵袭模式侵袭性及体外侵袭率正相关。
  • CD97敲低降低pdGSC体外侵袭率,在间质型和经典型pdGSC中最明显。
  • CD97过表达后体外侵袭率增加,主要见于前神经型pdGSC。
  • 在内源CD97水平最低的pdGSC系中,CD97过表达使增殖率增加近三倍。

临床怎么用

  • CD97可能作为削弱GBM侵袭的潜在治疗靶点,但需进一步体内和机制验证。
  • CD97对侵袭的影响因pdGSC亚型而异,未来干预需考虑亚型背景。

局限性

  • 研究仅基于体外pdGSC实验,缺乏体内验证。
  • CD97影响侵袭的机制尚未阐明。
  • CD97药理抑制剂尚未被识别和验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Effective glioblastoma (GBM) treatment is limited by high invasiveness and heterogeneity. Current therapies target proliferating Glioma Stem Cell (GSC) subpopulations while sparing invading GSCs, which eventually engender tumor recurrence after treatment. Surface receptor CD97/ADRGE5 is associated with invasion and metastasis regulation in non-CNS cancers. Although CD97 expression level positively correlates with poor GBM patient prognosis, its role in this tumor is unclear. METHODS: Here, we examined CD97 function in primary patient-derived GSCs (pdGSCs) obtained from five GBM tumors, belonging to three major genetic subtypes. We compared endogenous CD97 levels in pdGSCs to the corresponding patient MRI's radiographic invasion pattern aggressiveness. We manipulated CD97 levels in these pdGSCs by knockdown and overexpression and analyzed: (i) stem and subtype marker expression, (ii) in vitro invasive properties, and (iii) cell proliferation. RESULTS: Endogenous CD97 levels in pdGSCs positively correlated with radiographic invasion pattern aggressiveness on patient MRIs, and in vitro invasion rate. CD97 knockdown decreased pdGSC invasion rates in vitro, most markedly in mesenchymal subtype pdGSCs, as well as classical subtype pdGSCs. Invasion rates in vitro increased after CD97 overexpression predominately in proneural subtype pdGSCs. In the pdGSC line with the lowest endogenous CD97 level, CD97 overexpression increased the proliferation rate almost threefold. CONCLUSIONS: For the first time in pdGSCs, we have shown that CD97 knockdown decreases and overexpression increases invasion rate in vitro. The effect of CD97 on invasion is pdGSC subtype-dependent. Future in vivo and mechanistic studies are needed for validation. Pharmacologic CD97 inhibitors should be identified, as they may potentially therapeutically diminish GBM invasion.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Eichberg DG, Slepak TI, Pascoini AL, et al. Genetic manipulation of adhesion GPCR CD97/ADGRE5 modulates invasion in patient-derived glioma stem cells. J Neurooncol. 2021. PMID: 34028660. doi:10.1007/s11060-021-03778-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。